Human Hepatocyte Nuclear Factors (HNF1 and LXRb) Regulate CYP7A1 in HIV-Infected Black South African Women with Gallstone Disease: A Preliminary Study.

Suman Mewa Kinoo, Pragalathan Naidoo, Bhugwan Singh, Anil Chuturgoon, Savania Nagiah
Author Information
  1. Suman Mewa Kinoo: Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, College of Health Science, University of KwaZulu Natal, Glenwood, Durban 4041, South Africa.
  2. Pragalathan Naidoo: Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, College of Health Science, University of KwaZulu Natal, Glenwood, Durban 4041, South Africa.
  3. Bhugwan Singh: Discipline of General Surgery, School of Clinical Medicine, College of Health Science, University of KwaZulu Natal, Umbilo, Durban 4001, South Africa.
  4. Anil Chuturgoon: Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, College of Health Science, University of KwaZulu Natal, Glenwood, Durban 4041, South Africa. ORCID
  5. Savania Nagiah: Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, College of Health Science, University of KwaZulu Natal, Glenwood, Durban 4041, South Africa.

Abstract

Female sex, high estrogen levels, aging, obesity, and dyslipidemia are some of the risk factors associated with gallstone formation. HIV-infected patients on combination antiretroviral therapy (cART) are more prone to hypercholesterolemia. Bile acid synthesis is initiated by cholesterol 7-alpha hydroxylase (CYP7A1) and regulated by hepatocyte nuclear factors (HNF1α, HNF4α, and LXRb). The aim of this study was to evaluate the expression of HNF1α, HNF4α, LXRb, and miRNAs (HNF4α specific: miR-194-5p and miR-122_1) that regulate CYP7A1 transcription in HIV-infected Black South African women on cART and presenting with gallstones relative to HIV-negative patients with gallstone disease. Females ( = 96) presenting with gallstone disease were stratified based on HIV status. The gene expression of , , , , miR-194-5p, and miR-122_1 was determined using RT-qPCR. Messenger RNA and miRNA levels were reported as fold change expressed as 2 (RQ min; RQ max). Fold changes >2 and <0.5 were considered significant. HIV-infected females were older in age ( = 0.0267) and displayed higher low-density lipoprotein cholesterol (LDL-c) ( = 0.0419), [2.078-fold (RQ min: 1.278; RQ max: 3.381)], [2.595-fold (RQ min: 2.001; RQ max: 3.000)], and [3.428 (RQ min: 1.806; RQ max: 6.507] levels. [0.642-fold (RQ min: 0.266; RQ max: 1.55)], miR-194-5p [0.527-fold (RQ min: 0.37; RQ max: 0.752)], and miR-122*_1 [0.595-fold (RQ min: 0.332; RQ max: 1.066)] levels were lower in HIV-infected females. In conclusion, HIV-infected women with gallstone disease displayed higher LDL-c levels and increased bile acid synthesis, which was evidenced by the elevated expression of CYP7A1, HNF1α, and LXRb. This could have been further influenced by cART and aging.

Keywords

References

  1. AIDS. 1996 Oct;10(12):1385-91 [PMID: 8902068]
  2. J Biol Chem. 1997 Feb 7;272(6):3137-40 [PMID: 9013544]
  3. Eur Heart J. 2018 Jun 7;39(22):2106-2116 [PMID: 29529257]
  4. Postgrad Med J. 2001 Apr;77(906):221-9 [PMID: 11264482]
  5. J Biol Chem. 2017 Jun 23;292(25):10574-10585 [PMID: 28465351]
  6. Curr Atheroscler Rep. 2008 Feb;10(1):61-70 [PMID: 18366987]
  7. Nat Genet. 2001 Apr;27(4):375-82 [PMID: 11279518]
  8. J Lipid Res. 2009 Oct;50(10):1955-66 [PMID: 19346330]
  9. PLoS Biol. 2006 Oct;4(11):e365 [PMID: 17076584]
  10. J Infect Dis. 2015 Nov 15;212(10):1563-73 [PMID: 25969563]
  11. Lancet Infect Dis. 2013 Nov;13(11):964-75 [PMID: 24156897]
  12. Nat Med. 2004 Dec;10(12):1352-8 [PMID: 15558057]
  13. J Antimicrob Chemother. 2014 May;69(5):1385-9 [PMID: 24379301]
  14. J Hepatol. 2018 May;68(5):1033-1048 [PMID: 29175243]
  15. Biochem Biophys Res Commun. 1999 Jul 14;260(3):829-34 [PMID: 10403849]
  16. Front Genet. 2013 Jan 28;3:328 [PMID: 23372574]
  17. Ann Hepatol. 2006 Jul-Sep;5(3):140-9 [PMID: 17060869]
  18. PLoS One. 2020 Jul 9;15(7):e0235542 [PMID: 32645054]
  19. Mol Cell Biol. 2012 Apr;32(7):1226-36 [PMID: 22290433]
  20. Cell. 2000 Sep 29;103(1):1-4 [PMID: 11051540]
  21. Aust N Z J Med. 1996 Jun;26(3):368-71 [PMID: 8811210]
  22. Metabolism. 2010 Jun;59(6):767-73 [PMID: 20005541]
  23. Dig Liver Dis. 2004 Feb;36(2):130-4 [PMID: 15002821]
  24. J Lipid Res. 1996 Feb;37(2):223-8 [PMID: 9026521]
  25. J Hepatol. 2011 Sep;55(3):602-611 [PMID: 21241755]
  26. Postepy Hig Med Dosw (Online). 2007 Dec 03;61:736-59 [PMID: 18063918]
  27. J Biol Chem. 2000 Jul 21;275(29):21805-8 [PMID: 10823815]
  28. J Hepatol. 2001 Apr;34(4):492-9 [PMID: 11394647]
  29. J Clin Invest. 1968 May;47(5):1043-52 [PMID: 5645851]
  30. Curr HIV/AIDS Rep. 2016 Oct;13(5):289-96 [PMID: 27541600]
  31. Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):121-6 [PMID: 11788471]
  32. Cholesterol. 2013;2013:298421 [PMID: 23691293]
  33. Curr Med Chem. 2008;15(22):2271-84 [PMID: 18781949]
  34. Rambam Maimonides Med J. 2012 Oct 31;3(4):e0025 [PMID: 23908849]
  35. Gastroenterology. 2004 Mar;126(3):741-8 [PMID: 14988828]
  36. Curr Gastroenterol Rep. 2005 May;7(2):132-40 [PMID: 15802102]
  37. Open Cardiovasc Med J. 2011;5:49-63 [PMID: 21643501]
  38. Mol Endocrinol. 2003 Mar;17(3):386-94 [PMID: 12554795]
  39. Lancet. 1991 Nov 2;338(8775):1117-21 [PMID: 1682550]
  40. J Lipid Res. 2012 Apr;53(4):696-708 [PMID: 22262807]
  41. Transl Gastroenterol Hepatol. 2020 Apr 05;5:14 [PMID: 32258518]
  42. BMC Infect Dis. 2021 Mar 23;21(1):294 [PMID: 33757439]
  43. J Biol Chem. 2001 Aug 17;276(33):30708-16 [PMID: 11402042]
  44. Biochem Pharmacol. 2006 Aug 14;72(4):512-22 [PMID: 16806085]
  45. J Lipid Res. 2000 Jan;41(1):1-11 [PMID: 10627496]
  46. Nucleic Acids Res. 2004 Feb 11;32(3):1113-21 [PMID: 14960721]
  47. Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G1071-80 [PMID: 16861219]
  48. Hepatology. 2007 May;45(5):1261-6 [PMID: 17464999]
  49. World J Gastroenterol. 2005 Mar 21;11(11):1653-7 [PMID: 15786544]
  50. PLoS One. 2015 Sep 11;10(9):e0137660 [PMID: 26360703]
  51. J Aging Res. 2016;2016:2404857 [PMID: 27595022]
  52. AIDS Res Ther. 2013 Dec 13;10(1):32 [PMID: 24330597]
  53. mBio. 2014 Apr 29;5(3):e01031-13 [PMID: 24781743]
  54. J Lipid Res. 2003 Sep;44(9):1728-36 [PMID: 12777468]
  55. Gastroenterology. 2015 Dec;149(7):1731-1741.e3 [PMID: 26327134]
  56. Gastroenterology. 1975 Sep;69(3):676-84 [PMID: 1158085]
  57. Lancet HIV. 2017 Jul;4(7):e277 [PMID: 28668182]
  58. Gene. 2001 Jan 10;262(1-2):257-65 [PMID: 11179691]
  59. Crit Rev Clin Lab Sci. 2014 Apr;51(2):98-111 [PMID: 24479745]
  60. Biochem Pharmacol. 2004 Jan 15;67(2):255-67 [PMID: 14698038]
  61. J Biol Chem. 2003 Dec 12;278(50):50047-52 [PMID: 14522988]
  62. Am J Gastroenterol. 1989 Nov;84(11):1383-5 [PMID: 2683740]
  63. HIV Med. 2005 Mar;6(2):114-21 [PMID: 15807717]
  64. S Afr Med J. 1987 Jul 4;72(1):23-6 [PMID: 3603287]
  65. J Clin Invest. 2002 Jul;110(1):109-17 [PMID: 12093894]

Word Cloud

Created with Highcharts 10.0.0RQ0min:max:levelsHIV-infectedCYP7A1LXRb]gallstone1cARTHNF1αHNF4αexpressionmiR-194-5pdisease=[0agingfactorspatientsacidsynthesischolesterolmiR-122_1BlackSouthAfricanwomenpresentinggallstonesHIV2femalesdisplayedhigherLDL-c[23595-foldHNF1FemalesexhighestrogenobesitydyslipidemiariskassociatedformationcombinationantiretroviraltherapypronehypercholesterolemiaBileinitiated7-alphahydroxylaseregulatedhepatocytenuclearaimstudyevaluatemiRNAsspecific:regulatetranscriptionrelativeHIV-negativeFemales96stratifiedbasedstatusgenedeterminedusingRT-qPCRMessengerRNAmiRNAreportedfoldchangeexpressedminmaxFoldchanges>2<05consideredsignificantolderage0267low-densitylipoprotein0419078-fold278381001000[34288066507]642-fold26655527-fold37752miR-122*_1332066lowerconclusionincreasedbileevidencedelevatedinfluencedHumanHepatocyteNuclearFactorsRegulateHIV-InfectedWomenGallstoneDisease:PreliminaryStudy

Similar Articles

Cited By